Heart Rate News and Research

RSS

Heart rate is determined by the number of heartbeats per unit of time, typically expressed as beats per minute (BPM), it can vary with as the body's need for oxygen changes, such as during exercise or sleep.

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Merck announced today results from a new non-inferiority trial of an antiemetic regimen containing fosaprepitant dimeglumine administered as a single intravenous (IV) 150-mg dose in combination with a 5-HT3 antagonist and dexamethasone compared with a three-day regimen of aprepitant with a 5-HT3 antagonist and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving a first cycle of cisplatin-based chemotherapy.

4 Jun 2010

Freescale Semiconductor develops portable medical kiosk to run routine health screenings at home

As the population continues to age and medical monitoring becomes more integrated into everyday living, healthcare professionals are constantly striving to find new ways to monitor patients with improved accuracy, speed and end-user convenience. Taking an active part in this initiative, Freescale Semiconductor, partnering with Pounce Consulting, developed a portable, easy-to-use telemonitoring reference design, which allows patients and physicians to run routine health screenings at home or remotely.

4 Jun 2010

Healthcare facilities lack appropriate equipment, supplies to manage emergency situations: Report

Healthcare facilities sometimes lack the appropriate equipment and supplies to successfully manage an emergency in their facility in a timely manner, according to data released today by the Pennsylvania Patient Safety Authority and published in the June Pennsylvania Patient Safety Advisory.

2 Jun 2010

Brain's cardiovascular, hormonal and asymmetric activation response when we get angry: UV scientists

When we get angry, the heart rate, arterial tension and testosterone production increases, cortisol (the stress hormone) decreases, and the left hemisphere of the brain becomes more stimulated. This is indicated by a new investigation lead by scientists from the University of Valencia that analyses the changes in the brain's cardiovascular, hormonal and asymmetric activation response when we get angry.

31 May 2010

Overall increase of cesarean births not due to maternal request

Fewer than two per cent of cesarean births in British Columbia were a result of maternal request, but the number of cesarean and assisted vaginal deliveries varied widely across health regions in B.C., according to a new study by University of British Columbia researchers.

31 May 2010

Wireless monitoring system for people with debilitating conditions

A wireless monitoring system for people with debilitating conditions such as Parkinson's disease or chronic obstructive pulmonary disorder could allow healthcare workers to assess a patient's health and the development of their disease without hindering their movements. Details of the system are reported in the International Journal of Biomedical Engineering and Technology.

27 May 2010

UCSF research shows brief exercise buffers the effects of stress-induced cell aging

Exercise can buffer the effects of stress-induced cell aging, according to new research from UCSF that revealed actual benefits of physical activity at the cellular level.

27 May 2010

SunTech Medical's clinical-grade blood pressure technology selected for new Portable PFS

SunTech Medical, a leading manufacturer of blood pressure monitors and OEM non-invasive blood pressure modules, is pleased to announce the selection of their clinical-grade blood pressure technology for the new Portable Pulmonary Function System by Damec.

26 May 2010

Shire announces study results of Vyvanse Capsules CII for treatment of ADHD in adolescents

Shire plc, the global specialty biopharmaceutical company, today announced the results of a study evaluating the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder in adolescents aged 13 to 17 years.

26 May 2010

Masimo PVI identifies patients at high risk for developing severe hypotension during anesthesia induction

Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published in the May 2010 issue of Acta Anaesthesiologica Scandinavica shows that Masimo pleth variability index can be used to help clinicians assess risk for mean arterial pressure decreases and subsequent hypotension during anesthesia administration.

25 May 2010

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Bayer Inc. today responded to Professor Marvin Meyer's letter to the editor, entitled: "Critical questions concerning the validity of the Bayer study report of differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration" and published in the online edition of the International Journal of Clinical Pharmacology and Therapeutics. Bayer responded to the clinical relevance of the differences in formulation and dissolution behaviour and the delayed absorption of Mylan's extended release nifedipine.

25 May 2010

New findings on INTUNIV Extended Release Tablets presented at major psychiatric meeting

Shire plc, the global specialty biopharmaceutical company, today announced new findings on once-daily INTUNIV (guanfacine) Extended Release Tablets, the first selective alpha-2A agonist approved for the treatment of Attention Deficit Hyperactivity Disorder, at a major psychiatric meeting.

24 May 2010

MHAUS to discuss how medical facilities can best prepare for MH emergency

Preparation is the best plan for Malignant Hyperthermia emergencies, and The Malignant Hyperthermia Association of the United States will be at the Ambulatory Surgery Center Annual Meeting, May 19-22, to answer questions about how medical facilities can best prepare for an MH emergency.

20 May 2010

Initial results of MUSIC Trial using PD2i in chronic heart failure patients released

David H. Fater, CEO of Vicor Technologies, Inc., today announced the initial results of a study designed to analyze data from the Merte Subita en Insufficiencia Cardiaca Trial using its PD2i- algorithm and software. Vicor Technologies is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2i- nonlinear algorithm and software.

20 May 2010

Air pollution associated with cardiopulmonary mortality, morbidity: Researchers

Breathing polluted air increases stress on the heart's regulation capacity, up to six hours after inhalation of combustion-related small particles called PM2.5, according to Penn State College of Medicine researchers.

20 May 2010

Study identifies suppression as a mediator between negative emotions and desire to binge

A German study published in the current issue of Psychotherapy and Psychosomatics explores what is behind binge eating.

19 May 2010

Benefits of aerobic training outclass those of lower-intensity walking programs

What to do: walk around the block or work up a sweat in an aerobic workout at the gym? If you're looking for the best health benefits from an exercise program, a traditional aerobic fitness program that gets your heart pumping beats a walking program hands down. But if you want to get moving, a walking program is easier to do, it's good for you, and you're more likely to stick with it.

18 May 2010

Maternal stretching and meditation keep expecting mothers healthy during pregnancy: AAOS

Perfect for mind and body rejuvenation, yoga uses meditation and aligning movements to encourage fitness and relaxation. This low-impact fitness alternative allows pregnant women to continue an exercise regimen without putting strain on their heart or harming the baby.

18 May 2010

Merck, Cardiome Pharma show superiority of BRINAVESS to amiodarone injection

In a new Phase III study, BRINAVESSTM (vernakalant) intravenous, an investigational compound being developed in the European Union by Merck (known as MSD outside the USA and Canada) and Cardiome Pharma Corp. to treat atrial fibrillation, showed that BRINAVESS was superior to amiodarone injection, in converting patients' heart rate from atrial fibrillation (AF) to sinus rhythm (SR) within 90 minutes of the start of administration.

15 May 2010

GRNCM1 do not cause cardiac arrhythmias after transplantation: Preclinical study

Geron Corporation today reported positive preclinical study data showing that GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells, does not cause cardiac arrhythmias after transplantation into a model of chronic heart damage designed to test this potential safety concern.

14 May 2010

Heart Rate News and Research

Further Reading

Antiemetic-regimen with fosaprepitant injection provides similar protection against CINV as oral EMEND

Freescale Semiconductor develops portable medical kiosk to run routine health screenings at home

Healthcare facilities lack appropriate equipment, supplies to manage emergency situations: Report

Brain's cardiovascular, hormonal and asymmetric activation response when we get angry: UV scientists

Overall increase of cesarean births not due to maternal request

Wireless monitoring system for people with debilitating conditions

UCSF research shows brief exercise buffers the effects of stress-induced cell aging

SunTech Medical's clinical-grade blood pressure technology selected for new Portable PFS

Shire announces study results of Vyvanse Capsules CII for treatment of ADHD in adolescents

Masimo PVI identifies patients at high risk for developing severe hypotension during anesthesia induction

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

New findings on INTUNIV Extended Release Tablets presented at major psychiatric meeting

MHAUS to discuss how medical facilities can best prepare for MH emergency

Initial results of MUSIC Trial using PD2i in chronic heart failure patients released

Air pollution associated with cardiopulmonary mortality, morbidity: Researchers

Study identifies suppression as a mediator between negative emotions and desire to binge

Benefits of aerobic training outclass those of lower-intensity walking programs

Maternal stretching and meditation keep expecting mothers healthy during pregnancy: AAOS

Merck, Cardiome Pharma show superiority of BRINAVESS to amiodarone injection

GRNCM1 do not cause cardiac arrhythmias after transplantation: Preclinical study

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News